Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Oct;11(5):1270-1282.
doi: 10.1002/jcsm.12575. Epub 2020 Jun 1.

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis

Chan Mi Lee  1 , Jeonghyun Kang  2
Affiliations
Meta-Analysis

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis

Chan Mi Lee et al. J Cachexia Sarcopenia Muscle. 2020 Oct.

Abstract

Background: Myosteatosis has been reported to be a novel biomarker that could predict survival outcomes in patients with colorectal cancer. However, results have been conflicting. This systematic review and meta-analysis aimed to evaluate the long-term impact of myosteatosis on the survival of these patients.

Methods: A systematic search of PubMed, Embase, and Cochrane up to 27 November 2019 generated 7022 records. Studies that reported hazard ratio (HR) for overall survival, cancer-specific survival, or disease-free survival based on myosteatosis or radiodensity were included. A total of 110 full-text articles were considered for inclusion, and 14 were selected for qualitative analysis. Inverse variance method was used with random effects model for data analysis.

Results: The total number of enrolled patients included in the meta-analysis was 6518 for univariate and 8572 for multivariate HR analysis, from 12 and 10 studies, respectively. Patients with myosteatosis had a significant increase in overall mortality compared with non-myosteatosis patients by both univariate analysis [HR 1.38, 95% confidence interval (CI) 1.21 to 1.58, P < 0.00001] and multivariate analysis (HR 1.55, 95% CI 1.23 to 1.96, P < 0.00001). In subgroup analysis based on studies that reported HRs of both sarcopenia and myosteatosis, the negative effect of myosteatosis on overall survival was independent of sarcopenia using univariate values (sarcopenia HR 1.48, 95% CI 1.14 to 1.91, P = 0.003 vs. myosteatosis HR 1.51, 95% CI 1.17 to 1.96, P = 0.002) and multivariate values (sarcopenia HR 1.28, 95% CI 1.09 to 1.49, P = 0.002 vs. myosteatosis HR 1.38, 95% CI 1.07 to 1.80, P = 0.001).

Conclusions: This meta-analysis demonstrates that myosteatosis is associated with worse overall survival in patients with colorectal cancer. More investigation is needed to standardize the measurement protocol for myosteatosis and to further optimize its prognostic power for colorectal cancer patients.

Keywords: Colorectal cancer; Myosteatosis; Skeletal muscle density; Survival.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Flow diagram depicting the selection process for studies. HR, hazard ratio.
Figure 2
Figure 2
Meta‐analysis of univariate results reporting impact of myosteatosis on overall survival in patients with colorectal cancer using the random effects model. CI, confidence interval; df, degrees of freedom; IV, inverse variance; SE, standard error.
Figure 3
Figure 3
Meta‐analysis of multivariate results reporting impact of myosteatosis on (A) overall survival and (B) cancer‐specific survival in patients with colorectal cancer using the random effects model. CI, confidence interval; df, degrees of freedom; IV, inverse variance; SE, standard error.
Figure 4
Figure 4
Meta‐analysis of univariate results reporting impact of (A) sarcopenia and (B) myosteatosis by random effects model in studies that report both findings in the same study cohort. CI, confidence interval; df, degrees of freedom; IV, inverse variance; SE, standard error.
Figure 5
Figure 5
Meta‐analysis of multivariate results reporting impact of (A) sarcopenia and (B) myosteatosis by random effects model in studies that report both findings in the same study cohort. CI, confidence interval; df, degrees of freedom; IV, inverse variance; SE, standard error.
See this image and copyright information in PMC

References

    1. NCCN clinical practice guidelines in oncology, NCCN Guidelines for Treatment of Cancer by Site (2019). https://www.nccn.org/professionals/physician_gls/default.aspx (accessed September 2, 2019).
    1. Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta‐analysis. Sci Rep 2017;7:16717. - PMC - PubMed
    1. Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta‐analysis. Crit Rev Oncol Hematol 2017;116:134–146. - PubMed
    1. McSorley ST, Black DH, Horgan PG, McMillan DC. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin Nutr Edinb Scotl 2018;37:1279–1285. - PubMed
    1. Brown JC, Cespedes Feliciano EM, Caan BJ. The evolution of body composition in oncology—epidemiology, clinical trials, and the future of patient care: facts and numbers. J Cachexia Sarcopenia Muscle 2018;9:1200–1208. - PMC - PubMed